Fantastic overview on how to image the tricuspid valve - extremely useful for interventional cardiologists as well! @chrismeduri @GilbertTangMD @nickaram #TreatTR

Attending #EACVI2025 and interested in valvular heart disease? check out the programme and come to this session with @hahn_rt @FabienPraz @mirjam_wild @JoaoLCavalcante 👇👇👇@EACVIPresident

PCR Perspectives: How are the new ESC/EACTS valvular guidelines going to impact my tricuspid programme? 📺& 🎧 https://t.co/4FWjws1xZ3 @drmaisano and @FabienPraz explore changes in surgery, repair, replacement, and transcatheter interventions. Also available as a podcast!

Mitral &tricuspid valve interventions focus on imaging 🔝notch course directed by @ReginaRibeiras at @hospitaldaluz in Lisbon with world class simulators supported by @EdwardsLifesci @GEHealthCare @philips @manuelbarreirop

This new Consensus provided a comprehensive framework for managing patients with transvalvular CIED leads undergoing transcatheter #tricuspid interventions. It clarified mechanisms of lead–valve interaction, outlined risks and implications of lead jailing, and defined when lead

First part of the mitral and tricuspid valve course directed by @ReginaRibeiras in @hospital_da_luz fully packed, 🔝 notch lectures @NAjmoneMarsan @manuelbarreirop @ruiplacido @EACVIPresident this year with @PCRTricuspid focus group @didier_tchetche @FabienPraz

In the ENCIRCLE trial, percutaneous transseptal TMVR with SAPIEN M3 reduced mitral regurgitation with low rates of complications and mortality, making it a therapeutic option for patients who are unsuitable for surgery or TEER https://t.co/cAgXQq9typ @TheLancet @EdwardsLifesci

JUST OUT following my series of #Tricuspid posts! Our @JAMACardio review on Contemporary Management of #TricuspidRegurgitation included the latest evidence on medical, surgical and transcatheter treatment. Congrats @benjisalter @kentso987 for leading the effort along with all

Excellent TAVI workshop in Rouen with participants from Tunisia, Algeria, Morocco, Nepal, Brazil, France, Albania, Poland & Togo, plus live cases from Argentina, Toulouse, Ireland, Hong Kong & Rouen. Focus on key steps (access, V-i-V) and an afternoon of simulation & discussion!

Emerging evidence supporting transcatheter tricuspid interventions https://t.co/ZpsKsisEeB

El mejor congreso en habla hispana de intervencionismo coronario y estructural @shci_sec @secardiologia @icruzgonzalez @StructuralBCN @luisnombela @FabienPraz @PhilippLurz @SIAC_cardio

Exploring the inflammatory response to Transcatheter Aortic Valve Replacement - opening the door to new therapeutic strategies? https://t.co/6UMw3yUIX7

It’s the last day of PCR London Valves #PCRLV 2025, and at the end of the Opening Ceremony we could celebrate a special moment: Bernard Prendergast’s birthday. Happy birthday from all of us! 🎉🎂🎈

✅It's still time to register! 🤝Join @FabienPraz, @PhilippLurz, M. Adam and @drtpatterson today at 5pm (UTC+2) for this live #PCRWebinar: "TTVR: who to treat and how to implement into my practice" 🔗 https://t.co/jbzEgYwrgs #TricuspidValve #InterventionalCardiology

#TTVR: who to treat and how to implement into my practice 🗓️ Next live #PCRWebinar: Wednesday 12 November 2025, 5:00pm (UTC+1) 👨‍⚕️@FabienPraz, @PhilippLurz, M. Adam, @drtpatterson 🔗 Register now: https://t.co/DawqXZA2uu #InterventionalCardiology

Falta só um mês para o GaiaTricuspid 2025! Não perca a oportunidade de participar num curso intensivo sobre a abordagem contemporânea da patologia valvular tricúspide. Inscreva-se através do link – as vagas são limitadas! https://t.co/wykTK4xA7i @luispuga_cardio @CE_Guerreiro

Assessment of low-flow, low-gradient, severe aortic stenosis: cardiac catheterisation forms an integral part of the work-up of these patients in order to confirm or refute the echocardiographic findings to guide management decisions appropriately. https://t.co/QAwkSBlDVu.

🚨"How will the new valvular guidelines impact my tricuspid programme?", is live now🚨 @dottormaisano, @juliendreyfus1, @j_hausleiter & @masitges are waiting for you online📡 💻 Watch the live: https://t.co/2XoiMlhkTy #Tricuspid #InterventionalCardiology #PCRWebinar

⏰Remember to join @dottormaisano, @juliendreyfus1, @j_hausleiter & @masitges today at 5pm (UTC+2) for this #PCRWebinar on Tricuspid Valve! 🚀Ask questions, get answers! 🔗 https://t.co/2XoiMlhkTy #Tricuspid #InterventionalCardiology

Congratulations @bogdan_popescu1 for the excellent VHD Forum celebrated in Bucharest 👐handson session on transthoracic and trans esophageal echo 🩻data acquisition with the new Pioneer US system @GEHealthCare @GE_IanMc 🏩discussions on the new @escardio VHD guidelines

I have translated into slides the topics and references used by the 2025 Guidelines Task Force on valvular heart disease to justify the recommendation for TAVI in patients aged 70 years or older. Their key argument is a certain degree of pragmatism — they consider age as a